FDA-Inspected Site

Zhejiang Cheng Yi Pharmaceutical Co., Ltd

5 FDA inspections are on record for Zhejiang Cheng Yi Pharmaceutical Co., Ltd in Wenzhou, China.

483· Form 483 issued

Wenzhou, China · Last updated July 10, 2026

Overview

  • 5 FDA inspections are on record.
  • 5 inspections produced a Form 483.
  • The most recent recorded inspection date is 2025-03-07.

At a glance

Inspections

5

Form 483s

5

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
3 Mar 2025 – 7 Mar 2025Human Drugs483On file
18 Nov 2019 – 22 Nov 2019Human Drugs483View 483 →
12 Jul 2016 – 15 Jul 2016Human Drugs483On file
10 Mar 2014 – 14 Mar 2014Human Drugs483On file
9 Sep 2010Not recorded483On file

Observations on record

Form 483 observations cited at this site, most recent first.

22 Nov 2019
21 CFR 211.100(a)

Approval and review of procedures

Cited by Santos E Camara

22 Nov 2019
21 CFR 211.110(a)

Control procedures to monitor and validate performance

Cited by Santos E Camara

22 Nov 2019
21 CFR 211.142(b)

Storage under appropriate conditions

Cited by Santos E Camara

22 Nov 2019
21 CFR 211.22(a)

Authority lacking to review records, investigate errors

Cited by Santos E Camara

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.110(a)Cited across public-safe Form 483 observations1x
21 CFR 211.142(b)Cited across public-safe Form 483 observations1x
21 CFR 211.22(a)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Zhejiang Cheng Yi Pharmaceutical Co., Ltd's 5 Form 483s

Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat